CIK 0001783183 · Non-accelerated filer<br>Smaller reporting company
Phathom Pharmaceuticals, Inc.
Sign in to watch- Ticker
- PHAT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 824151574
- Phone
- (877) 742-8466
- Business address
- 100 CAMPUS DRIVE,, SUITE 102, FLORHAM PARK, NJ, 07932
- 4 Open-market sale Director sold 40,000 shares at an average $35.70 ($1,428,038)
- 4 Open-market sale Chief Operating Officer sold 14,500 shares at an average $33.61 ($487,275)
- 8-K Event Material agreement
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market sale Director sold 79,658 shares at an average $43.42 ($3,458,896)
- 424B5 Offering Prospectus
- 8-K Event Other events
- 424B5 Offering Prospectus
- 8-K Event Other events
- 4 Open-market sale Chief Operating Officer sold 14,500 shares at an average $44.74 ($648,688)
- 8-K Event Other events
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 4 Open-market sale Director sold 30,342 shares at an average $41.30 ($1,253,198)
- S-3 Offering Registration Statement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale Chief Operating Officer sold 14,500 shares at $36.83 ($534,026)
- 8-K Event Bylaws or fiscal year change
Page 21 of 25 · 496 filings